Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

ClinicalTrials.gov ID: NCT00002445

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00002445. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 12:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Placebo Controlled and Double Blinded Study of IM862 for Patients With Muco-Cutaneous AIDS Associated Kaposi's Sarcoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if it is safe and effective to use IM862 to treat Kaposi's sarcoma (KS) in AIDS patients.

Study identification

NCT ID
NCT00002445
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cytran
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
AIDS Healthcare Foundation Los Angeles California 90027 —
LAGLC Los Angeles California 90028 —
USC School of Medicine / Norris Cancer Hosp Los Angeles California 90033 —
Tower ID Med Associates Los Angeles California 90048 —
UCLA Care Ctr Los Angeles California 90095 —
UCSD Med Ctr San Diego California 92103 —
UCSF - San Francisco Gen Hosp San Francisco California 94110 —
Conant Med Ctr San Francisco California 94117 —
Univ of Miami School of Medicine Miami Florida 331361013 —
BioQuan Research Group North Miami Florida 33161 —
Grady Mem Hosp Atlanta Georgia 30308 —
Northwestern Univ Chicago Illinois 60611 —
Infectious Disease of Indiana Indianapolis Indiana 46218 —
Johns Hopkins Oncology Baltimore Maryland 21231 —
Massachusetts Gen Hosp Boston Massachusetts 02114 —
Boston Med Ctr Boston Massachusetts 02118 —
Beth Israel Med Ctr Boston Massachusetts 02215 —
Washington Univ School of Medicine St Louis Missouri 63110 —
UMDNJ - New Jersey Med School Newark New Jersey 071032757 —
St Vincents Hosp / Clinical Research Program New York New York 10011 —
New York Univ Med Ctr New York New York 10016 —
Mem Sloan - Kettering Cancer Ctr New York New York 10021 —
Columbia-Presbyterian Hosp New York New York 10032 —
Albert Einstein Comprehensive Ctr The Bronx New York 10461 —
Case Western Reserve Univ Cleveland Ohio 44106 —
Ohio State Univ Columbus Ohio 43210 —
Pennsylvania Oncology and Hematology Associates Philadelphia Pennsylvania 19106 —
Vanderbilt Cancer Ctr Nashville Tennessee 37232 —
Cytran Inc Kirkland Washington 98033 —
Virginia Mason Med Ctr Seattle Washington 98101 —
Univ of Washington / Harborview Med Ctr Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Nov 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.